<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jin YH</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>National Research Council of Science and Technology</funding><pagination>E1787</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7465974</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(8)</volume><pubmed_abstract>Theiler's murine encephalomyelitis virus (TMEV) induces immune-mediated inflammatory demyelinating disease in susceptible mice that is similar to human multiple sclerosis (MS). In light of anti-CD20 therapies for MS, the susceptibility of B cells to TMEV infection is particularly important. In our study, direct viral exposure to macrophages and lymphocytes resulted in viral replication and cellular stimulation in the order of DCs, macrophages, B cells, and T cells. Notably, B cells produced viral proteins and expressed elevated levels of CD69, an activation marker. Similarly, the expression of major histocompatibility complex class II and costimulatory molecules in B cells was upregulated. Moreover, TMEV-infected B cells showed elevated levels of antigen-presenting function and antibody pr</pubmed_abstract><journal>Cells</journal><pubmed_title>Infection and Activation of B Cells by Theiler's Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis.</pubmed_title><pmcid>PMC7465974</pmcid><funding_grant_id>RO1 NS28752, RO1 NS33008</funding_grant_id><funding_grant_id>CRC-16-01-KRICT, NSN1621350</funding_grant_id><pubmed_authors>Jin YH</pubmed_authors><pubmed_authors>Kim CX</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Kim BS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Infection and Activation of B Cells by Theiler's Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis.</name><description>Theiler's murine encephalomyelitis virus (TMEV) induces immune-mediated inflammatory demyelinating disease in susceptible mice that is similar to human multiple sclerosis (MS). In light of anti-CD20 therapies for MS, the susceptibility of B cells to TMEV infection is particularly important. In our study, direct viral exposure to macrophages and lymphocytes resulted in viral replication and cellular stimulation in the order of DCs, macrophages, B cells, and T cells. Notably, B cells produced viral proteins and expressed elevated levels of CD69, an activation marker. Similarly, the expression of major histocompatibility complex class II and costimulatory molecules in B cells was upregulated. Moreover, TMEV-infected B cells showed elevated levels of antigen-presenting function and antibody pr</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-05-29T20:43:34.501Z</modification><creation>2025-05-29T20:43:34.501Z</creation></dates><accession>S-EPMC7465974</accession><cross_references><pubmed>32727036</pubmed><doi>10.3390/cells9081787</doi></cross_references></HashMap>